Odyssey Therapeutics, Inc. (ODTX)
Data as of , from SEC Form 4 filings.
See up to 3 months of ODTX. The 7-day demo opens the 1M and 3M ranges and puts ODTX on your watchlist.
Start 7-day demoLatest ODTX insider trades
About Odyssey Therapeutics, Inc. (ODTX)
Odyssey Therapeutics, Inc. is an SEC registrant, filing under CIK 0001882782, classified as biological products (no diagnostic substances). It is grouped with Health Care companies on this site. Its offering priced on 8 May 2026 and it trades on NASDAQ.
ODTX Form 4 activity by transaction type, last 90 days
No Form 4 activity for ODTX in the last 90 days.
ODTX insider transactions (Form 4)
7915 Form 4 filings on record, the earliest from May 12, 2026, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| TPG GP A, LLC | Other | Common Stock | 423,111 | - footnote F3 | - | |
| TPG GP A, LLC | Other | Common Stock | 2,351 | $18.00 footnote F3 | $42K | |
| TPG GP A, LLC | Other | Common Stock | 1,880,497 | - footnote F4 | - | |
| TPG GP A, LLC | Open-market purchase | Common Stock | 1,388,889 | $18.00 | $25.00M | |
| TPG GP A, LLC | Other | Warrants (right to buy) | 423,111 | - footnote F3 | - | |
| TPG GP A, LLC | Other | Series D Preferred Stock | 18,272,789 | - footnote F4 | - | |
| ||||||
| Dimension Capital II, L.P. - Director | Other | Common Stock | 1,709,543 | - footnote F1 | - | |
| Dimension Capital II, L.P. - Director | Open-market purchase | Common Stock | 1,111,111 | $18.00 | $20.00M | |
| Dimension Capital II, L.P. - Director | Other | Series D Convertible Preferred Stock | 16,611,626 | - footnote F1 | - | |
| ||||||
| SR ONE CAPITAL MANAGEMENT, LLC | Other | Common Stock | 474,048 | - footnote F1 | - | |
| SR ONE CAPITAL MANAGEMENT, LLC | Other | Common Stock | 139,366 | - footnote F3 | - | |
| SR ONE CAPITAL MANAGEMENT, LLC | Other | Common Stock | 59,692 | - footnote F4 | - | |
| SR ONE CAPITAL MANAGEMENT, LLC | Other | Common Stock | 61,762 | - footnote F5 | - | |
| SR ONE CAPITAL MANAGEMENT, LLC | Other | Common Stock | 683,817 | - footnote F6 | - | |
| SR ONE CAPITAL MANAGEMENT, LLC | Other | Common Stock | 191,541 | - footnote F7 | - | |
| SR ONE CAPITAL MANAGEMENT, LLC | Open-market sale | Common Stock | 1,065 footnote F8 | $18.00 | $19K | |
| SR ONE CAPITAL MANAGEMENT, LLC | Open-market purchase | Common Stock | 222,222 | $18.00 | $4.00M | |
| SR ONE CAPITAL MANAGEMENT, LLC | Other | Common Stock | 118,512 | - footnote F1 | - | |
| SR ONE CAPITAL MANAGEMENT, LLC | Other | Common Stock | 255,823 | - footnote F4 | - | |
| SR ONE CAPITAL MANAGEMENT, LLC | Other | Common Stock | 204,658 | - footnote F4 | - | |
| SR ONE CAPITAL MANAGEMENT, LLC | Other | Common Stock | 20,582 | - footnote F5 | - | |
| SR ONE CAPITAL MANAGEMENT, LLC | Other | Common Stock | 166,168 | - footnote F6 | - | |
| SR ONE CAPITAL MANAGEMENT, LLC | Other | Common Stock | 49,850 | - footnote F7 | - | |
| SR ONE CAPITAL MANAGEMENT, LLC | Open-market sale | Common Stock | 277 footnote F11 | $18.00 | $5K | |
| SR ONE CAPITAL MANAGEMENT, LLC | Open-market purchase | Common Stock | 133,333 | $18.00 | $2.40M | |
| SR ONE CAPITAL MANAGEMENT, LLC | Other | Common Stock | 463,106 | - footnote F5 | - | |
| SR ONE CAPITAL MANAGEMENT, LLC | Other | Common Stock | 273,527 | - footnote F6 | - | |
| SR ONE CAPITAL MANAGEMENT, LLC | Other | Common Stock | 78,656 | - footnote F7 | - | |
| SR ONE CAPITAL MANAGEMENT, LLC | Open-market sale | Common Stock | 438 footnote F13 | $18.00 | $8K | |
| SR ONE CAPITAL MANAGEMENT, LLC | Open-market purchase | Common Stock | 200,000 | $18.00 | $3.60M | |
| SR ONE CAPITAL MANAGEMENT, LLC | Other | Series A Convertible Preferred Stock | 4,606,320 | - footnote F1 | - | |
| SR ONE CAPITAL MANAGEMENT, LLC | Other | Series A-2 Convertible Preferred Stock | 1,299,842 | - footnote F3 | - | |
| SR ONE CAPITAL MANAGEMENT, LLC | Other | Series B Convertible Preferred Stock | 544,162 | - footnote F4 | - | |
| SR ONE CAPITAL MANAGEMENT, LLC | Other | Series C Convertible Preferred Stock | 600,142 | - footnote F5 | - | |
| SR ONE CAPITAL MANAGEMENT, LLC | Other | Series D Convertible Preferred Stock | 6,644,650 | - footnote F6 | - | |
| SR ONE CAPITAL MANAGEMENT, LLC | Other | Series D Warrants (Right to Buy) | 1,861,211 | - footnote F7 | - | |
| SR ONE CAPITAL MANAGEMENT, LLC | Other | Series A Convertible Preferred Stock | 1,151,580 | - footnote F1 | - | |
| SR ONE CAPITAL MANAGEMENT, LLC | Other | Series B Convertible Preferred Stock | 2,374,981 | - footnote F4 | - | |
| SR ONE CAPITAL MANAGEMENT, LLC | Other | Series B Convertible Preferred Stock | 1,899,984 | - footnote F4 | - | |
| SR ONE CAPITAL MANAGEMENT, LLC | Other | Series C Convertible Preferred Stock | 200,000 | - footnote F5 | - | |
| SR ONE CAPITAL MANAGEMENT, LLC | Other | Series D Convertible Preferred Stock | 1,614,650 | - footnote F6 | - | |
| SR ONE CAPITAL MANAGEMENT, LLC | Other | Series D Warrants (Right to Buy) | 484,395 | - footnote F7 | - | |
| SR ONE CAPITAL MANAGEMENT, LLC | Other | Series C Convertible Preferred Stock | 4,500,000 | - footnote F5 | - | |
| SR ONE CAPITAL MANAGEMENT, LLC | Other | Series D Convertible Preferred Stock | 2,657,860 | - footnote F6 | - | |
| SR ONE CAPITAL MANAGEMENT, LLC | Other | Series D Warrants (Right to Buy) | 764,312 | $0.00 | - | |
| ||||||
| Open-market purchase | Common Stock | 5,000 | $20.00 | $100K | ||
| Other | Common Stock | 28,698 | - footnote F1,F2,F3 | - | ||
| Option exercise | Common Stock | 2,963 | - footnote F5 | - | ||
| Tax withholding / forfeiture | Common Stock | 17 footnote F6 | $18.00 | $306 | ||
| Other | Series B Convertible Preferred Stock | 79,166 | - footnote F1 | - | ||
| Other | Series C Convertible Preferred Stock | 100,000 | - footnote F2 | - | ||
| Grant or award | Stock Option (Right to Buy) | 626,220 | $0.00 | - | ||
| Other | Series D Convertible Preferred Stock | 96,002 | - footnote F3 | - | ||
| Option exercise | Series D Warrants (Right to Buy) | 28,800 | - footnote F5 | - | ||
| ||||||
| Jason Haas - Officer | Open-market purchase | Common Stock | 1,000 | $20.00 | $20K | |
| Nan (Ln) Li | Other | Common Stock | 1,709,543 | - footnote F1 | - | |
| Nan (Ln) Li | Open-market purchase | Common Stock | 1,111,111 footnote F3 | $18.00 | $20.00M | |
| Nan (Ln) Li | Other | Series D Convertible Preferred Stock | 16,611,626 | - footnote F1 | - | |
| ||||||
| Grant or award | Stock Option (Right to Buy) | 27,393 | $0.00 | - | ||
| Valerie Odegard | Grant or award | Stock Option (Right to Buy) | 27,393 | $0.00 | - | |
| Shelley Chu | Open-market purchase | Common Stock | 11,111 footnote F1 | $18.00 | $200K | |
| ||||||
| Ourania Tatsis | Grant or award | Stock Option (Right to Buy) | 27,393 | $0.00 | - | |
| Natalie Dales - Officer | Grant or award | Stock Option (Right to Buy) | 79,773 | $0.00 | - | |
| Grant or award | Stock Option (Right to Buy) | 27,393 | $0.00 | - | ||
| Grant or award | Stock Option (Right to Buy) | 884,450 | $0.00 | - | ||
| Other | Common Stock | 27,386 | - footnote F1,F2 | - | ||
| Other | Series C Convertible Preferred Stock | 100,000 | - footnote F1 | - | ||
| Other | Series D Convertible Preferred Stock | 166,116 | - footnote F2 | - | ||
| ||||||
| Anthony W. Opipari - Officer | Option exercise | Common Stock | 541 | - footnote F5 | - | |
| Anthony W. Opipari - Officer | Other | Common Stock | 6,965 | - footnote F1,F2,F3,F4 | - | |
| Anthony W. Opipari - Officer | Tax withholding / forfeiture | Common Stock | 4 footnote F6 | $18.00 | $72 | |
| Anthony W. Opipari - Officer | Other | Series A Convertible Preferred Stock | 18,531 | - footnote F1 | - | |
| Anthony W. Opipari - Officer | Other | Series B Convertible Preferred Stock | 11,083 | - footnote F2 | - | |
| Anthony W. Opipari - Officer | Other | Series C Convertible Preferred Stock | 20,000 | - footnote F3 | - | |
| Anthony W. Opipari - Officer | Other | Series D Convertible Preferred Stock | 17,545 | - footnote F4 | - | |
| Anthony W. Opipari - Officer | Grant or award | Stock Option (Right to Buy) | 250,203 | $0.00 | - | |
| Anthony W. Opipari - Officer | Grant or award | Stock Option (Right to Buy) | 27,777 | $0.00 | - | |
| Anthony W. Opipari - Officer | Option exercise | Series D Warrants (Right to Buy) | 5,263 | - footnote F5 | - | |
| ||||||
| Collin M. Todd - Officer | Grant or award | Stock Option (Right to Buy) | 93,904 | $0.00 | - | |
ODTX insider trading FAQ
What is the latest insider trade for ODTX?
Odyssey Therapeutics, Inc. (ODTX) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-05-13. The full record for ODTX runs to 15 Form 4 filings, the earliest from 2026-05-12. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying ODTX stock?
No insider purchases of ODTX were filed in the last 90 days. 9 purchases are on record for this company.
How many insiders are selling ODTX stock?
No insider sales of ODTX were filed in the last 90 days. 3 sales are on record for this company.
Where can I see ODTX SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects ODTX Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - TPG GP A, LLC view on EDGAR
- - Dimension Capital II, L.P. view on EDGAR
- - SR ONE CAPITAL MANAGEMENT, LLC view on EDGAR
- - Jeffrey M. Leiden view on EDGAR
- - Jason Haas view on EDGAR
- - Nan (Ln) Li view on EDGAR
- - Ian F. Smith view on EDGAR
- - Valerie Odegard view on EDGAR
- - Shelley Chu view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where ODTX's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow ODTX with a 7-day demo
- ODTX on your watchlist
- Every ODTX Form 4 filing on record
- Up to 3 months of ODTX price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive